Scientists discover critical role of peroxisomes in protecting insulin and beta cells

At the LSU Pennington Biomedical Research Center, scientists have uncovered a critical role for peroxisomes in protecting insulin and maintaining the health of pancreatic beta cells. The findings, published in JCI Insight, shed light on how disruptions in peroxisome function can contribute to insulin-related issues and potentially diabetes.

Peroxisomes are small structures within cells that help manage cellular damage and break down fats. In a groundbreaking study, researchers disrupted peroxisomes in animal models and observed that this impairment led to several detrimental effects on beta cells. Specifically, the study revealed that peroxisome dysfunction promoted oxidative stress, altered the chemical structure of insulin, and reduced signs of beta cell maturity. Despite these negative impacts, the animals produced more insulin in response to sugar, yet struggled to maintain normal blood sugar levels.

"This study helps us understand the complex interplay between cellular metabolism, oxidative stress, and insulin integrity," said Dr. Jason Collier, Director of the Islet Biology and Inflammation Laboratory at Pennington Biomedical. "Peroxisomes play a crucial role in protecting beta cells from oxidative damage and maintaining their mature identity."

The research team used genetically modified animal models to delete the gene Pex5, which is essential for peroxisome function, specifically in pancreatic cells and insulin-producing beta cells. By evaluating glucose tolerance, insulin secretion, oxidative stress, metabolism, and markers of beta cell maturity, the researchers gained valuable insights into the impact of peroxisome dysfunction.

"Healthy beta cells have a unique ability to produce and release insulin efficiently. Our findings suggest that impaired peroxisome function compromises this process, leading to increased oxidative stress and reduced beta cell maturity," explained Dr. Susan Burke, Director of the Immunogenetics Laboratory at Pennington Biomedical.

Interestingly, the effects of peroxisome impairment differed between male and female animal models. Male animals exhibited more pronounced metabolic issues, including glucose intolerance and increased insulin secretion, while females showed a milder response. However, both genders demonstrated reduced beta cell maturity, indicating a gender-specific impact on beta cell function.

The study highlights the importance of maintaining peroxisome function for the health of beta cells and the production of insulin. "These findings provide new insights into the relationship between cellular metabolism, oxidative stress, insulin integrity, and beta cell health," Dr. Burke noted. "Further research is needed to determine whether impaired peroxisome function contributes to beta cell dysfunction in people with obesity, prediabetes, diabetes, or other metabolic diseases."

The research, led by Drs. Collier and Burke and involving collaborators from The University of Tennessee, Vanderbilt University Medical Center, and The University of Alabama at Birmingham, was supported by the National Institutes of Health through a P20 award to Dr. Burke.

"These results could have significant implications for our understanding of type 2 diabetes and potentially lead to new therapeutic strategies to protect beta cells and maintain healthy insulin production," Dr. Collier concluded.